cro.directory
Home
Inotiv logo

Inotiv

Integrated preclinical CRO with toxicology, bioanalysis, and specialized research models.

Inotiv provides integrated preclinical and safety assessment services including toxicology, bioanalysis, pathology, and specialized research models across discovery through IND-enabling phases.

Phases

Indications / Therapeutic Areas

Services

Modalities

Technical specifications & accreditations

Accreditations

About this organization

Inotiv is a contract research organization offering comprehensive preclinical and safety assessment services to support drug development across multiple therapeutic areas. Core capabilities include:

Discovery & Translational Sciences

  • Disease pharmacology (in vitro and in vivo)
  • Drug metabolism and pharmacokinetics (DMPK)
  • Discovery bioanalysis and biomarkers
  • Cell and molecular biology
  • Predictive and computational toxicology
  • Toxicogenomics
  • Targeted proteomics
  • Histology and pathology
  • Consultative drug discovery programs

Safety Assessment

  • Toxicology services (exploratory, genetic, safety pharmacology, developmental/reproductive, carcinogenicity)
  • GLP bioanalysis for large and small molecules
  • Impurities assessment
  • Medical device testing and surgical support
  • Cell and gene therapy assessment
  • SEND data management

Research Models & Services

  • Genetically engineered models and services (GEMS)
  • Full spectrum health monitoring
  • Custom antibody production
  • Biospecimen services
  • Contract breeding
  • Genetic testing
  • Surgical services

Therapeutic Area Expertise Cardiovascular, gastrointestinal, hepatic, infectious disease, inflammation and immunology, metabolic and diabetic disease, neuroscience, pulmonary, oncology, and renal.

Similar profiles by shared services, phases, and indications.

Submit a verified review for this organization.

Markdown mirror: /companies/inotivco.md